SHANGHAI, Oct. 30, 2025 /PRNewswire/ — Lufax Holding Ltd (NYSE: LU and HKEX: 6623), ("Lufax", or the "Company"), a leading financial services enabler for small business owners in China, today announced that the New York Stock Exchange (the "NYSE") has granted the Company an extension through April 30, 2026 to file the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2024 (the "2024 20-F") with the U.S. Securities and Exchange Commission, subject to reassessment on an ongoing basis.

The Company had previously reported that it would be delayed in its filing of the 2024 20-F due to the proposed change in the Company’s auditors in 2025 and announced that it had received notice from the NYSE that it was not fully in compliance with the NYSE’s continued listing standards. It has since appointed Ernst & Young and Ernst & Young Hua Ming LLP as its auditors. The Company continues to work diligently with its independent auditors to finalize and file the 2024 20-F as soon as possible.

The Company will continue to cooperate with the NYSE in this matter.  If the Company fails to file the 2024 20-F by April 30, 2026, suspension and delisting procedures will commence. The Company intends to regain compliance with the NYSE’s continued listing standards by filing the annual report within the NYSE’s prescribed timelines.

About Lufax

Lufax is a leading financial services enabler for small business owners in China. Lufax offers financing products designed to address the needs of small business owners and others. In doing so, Lufax has established relationships with 85 financial institutions in China as funding partners, many of which have worked with Lufax for over three years.

Investor Relations Contact

Lufax Holding LtdEmail: Investor_Relations@lu.com    ICR, LLCRobin YangTel: +1 (646) 308-0546Email: lufax.ir@icrinc.com

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

i2 increases investment in intelligence analysis software to strengthen agencies' pursuit of 'bad actors'

LONDON and NEW YORK, Aug. 9, 2024 /PRNewswire/ — Today, i2 Group said increasing…

Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease

Nine-month findings show mean improvement in Composite Unified Huntington’s Disease Rating Scale…

BRImo Mobile Banking, a Worldwide Simplicity in Your Hand

JAKARTA, Indonesia, Jan. 9, 2025 /PRNewswire/ — PT Bank Rakyat Indonesia (BRI)…